Overall, the study strongly supports DSIP as a promising therapeutic agent for functional recovery after ischemic stroke [1]
Your provider may need to evaluate for underlying conditions such as hypothyroidism, Cushing's syndrome, polycystic ovary syndrome, or other hormonal imbalances that can cause weight gain independent of tirzepatide therapy
Microdosing GLP-1 for Autoimmune Conditions According to a comprehensive systematic review published in 2024, treatment with GLP-1 receptor agonists results in significant reductions in disease severity among patients with psoriasis
Although no specific therapeutic applications in clinical trials have been found for let-7i-5p, miR-146b-5p, and miR-185-5p, these miRNAs have been identified as targets for mitigating the adverse effects of macrophage antigen presentation (Deng et al., 2022), suggesting they may play a role in modulating inflammatory responses
Those using tirzepatide with glycine formulations are already getting one of the key amino acids found in collagen
The results showed that oral administration of L-carnitine significantly reduced scratching behavior compared to the control group, confirming its antipruritic potential